North East and North Cumbria
ICS Formulary
Home
About
Admin
netFormulary
Chapters
Medicines A-Z
News
Mobile
Reports
Feedback
Search
Recent Updates - Updated items
All Formulary Amendments
Records 1 to 9 of 9
Details
UPD
NHSE Changed from N
27/07/2022 14:49:07
(DavidS )
UPD
sitematrix Changed from 0 to
27/07/2022 14:49:07
(DavidS )
UPD
FurtherInformation Changed from
Approved for the treatment of locally advanced or metastatic breast cancer after 2 or more chemotherapy regimens in accordance with NICE and NHS England Commissioning Policy
to
Approved f
27/07/2022 14:49:07
(DavidS )
UPD
Eribulin (Halaven
®
) updated
27/07/2022 14:49:07
(DavidS )
UPD
Eribulin (Halaven
®
) updated
30/05/2017 08:57:19
(DavidS )
UPD
Eribulin (Halaven
®
) updated information regarding NICE TA
20/04/2017 11:39:03
(DavidS )
UPD
Eribulin (Halaven
®
) b
01/02/2017 14:38:01
(DavidS )
LDL
Link Added : NICE TA423: Eribulin for treating locally advanced or metastatic breast cancer after 2 or more chemotherapy regimens : https://www.nice.org.uk/guidance/TA423
31/01/2017 15:56:29
(DavidS )
UPD
Eribulin (Halaven
®
) NICE TA423 approval
31/01/2017 15:55:44
(DavidS )
